Skip to content

Hepatitis B reactivation is rare after switching from tenofovir, two European studies show

Dr Alberto Foncillas presenting the Barcelona study at EACS 2025. He is speaking at a podium in front of a screen.

Second Berlin patient has unusual immune response that seems to have removed his HIV

Timo Trenkner presenting at EACS 2025. Timo is standing at a podium, talking into a microphone, with a screen and panel of people next to him.

Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options

Dr Maria Mazzitelli at EACS 2025. She is speaking into a microphone at a podium.

More Europeans are dying from HIV now than 15 years ago

Teymur Noori presenting at EACS 2025. He is speaking at a podium with a large screen behind him showing his presentation.

People with HIV report little difference in quality of life compared with matched controls, but more depression

Kevin Moody talking in to a microphone at EACS 2025.

Turning HIV’s power against itself may help target hidden virus – another step towards a cure

Close-up of a researcher working in a lab. She is wearing white surgical gloves and a white lab coat.

Low-level but detectable HIV raises the risk of treatment failure, but not long-term harm

Vials of blood in test tubes. One of them is being held by someone wearing white gloves.

Despite U=U, concerns about sharing HIV status persist among older people

An older man is sitting on a bench outside, looking upset. A woman sits next to him, with her arm on his shoulder, comforting him.

Trans and gender diverse people face multiple barriers accessing UK sexual health services

Transfeminine and non-binary colleagues talking in an office.